These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4054257)

  • 1. Severe chronic airflow obstruction: can corticosteroids slow down progression?
    Postma DS; Steenhuis EJ; van der Weele LT; Sluiter HJ
    Eur J Respir Dis; 1985 Jul; 67(1):56-64. PubMed ID: 4054257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
    Postma DS; Peters I; Steenhuis EJ; Sluiter HJ
    Eur Respir J; 1988 Jan; 1(1):22-6. PubMed ID: 3366234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility.
    Postma DS; Gimeno F; van der Weele LT; Sluiter HJ
    Eur J Respir Dis; 1985 Nov; 67(5):360-8. PubMed ID: 3878797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Eur Respir J; 1991 Nov; 4(10):1185-90. PubMed ID: 1804665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of chronic obstructive pulmonary disease: the Dutch experience.
    Postma DS; Sluiter HJ
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S100-5. PubMed ID: 2782755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL; Alexander MR
    Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of corticosteroids in the management of chronic obstructive lung disease: factors predicting response.
    Goel A; Suri JC; Aggarwal K
    Indian J Chest Dis Allied Sci; 1992; 34(1):11-7. PubMed ID: 1521875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
    Morice AH; Morris D; Lawson-Matthew P
    Clin Pharmacol Ther; 1996 Dec; 60(6):675-8. PubMed ID: 8988070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease.
    Osmanliev DP; Joyce H; Watson RA; Pride NB
    Respir Med; 2005 Aug; 99(8):1053-60. PubMed ID: 15950148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Course and prognosis of chronic obstructive lung disease over 5 and 10 years].
    Brändli O; Langloh P; Plangger M; Dreher D
    Schweiz Med Wochenschr; 1988 Sep; 118(37):1314-20. PubMed ID: 3175577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
    Boothman-Burrell D; Delany SG; Flannery EM; Hancox RJ; Taylor DR
    N Z Med J; 1997 Oct; 110(1053):370-3. PubMed ID: 9364183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.
    Cottin V; Khouatra C; Dubost R; Glérant JC; Cordier JF
    Allergy; 2009 Apr; 64(4):589-95. PubMed ID: 19154547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of high-dose beclomethasone in patients with stable chronic obstructive pulmonary disease].
    Koyama H; Nishimura K; Ikeda A; Tsukino M; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):410-5. PubMed ID: 7791269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD).
    Sandek K; Bratel T; Lagerstrand L
    Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.
    Pantin CF; Stead RJ; Hodson ME; Batten JC
    Thorax; 1986 Jan; 41(1):34-8. PubMed ID: 3518129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction.
    Postma DS; de Vries K; Koëter GH; Sluiter HJ
    Am Rev Respir Dis; 1986 Aug; 134(2):276-80. PubMed ID: 2874759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to oral corticosteroids in chronic airflow obstruction.
    Lam WK; So SY; Yu DY
    Br J Dis Chest; 1983 Apr; 77(2):189-98. PubMed ID: 6347233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of steroid responsiveness in patients with chronic airflow obstruction.
    Stokes TC; Shaylor JM; O'Reilly JF; Harrison BD
    Lancet; 1982 Aug; 2(8294):345-8. PubMed ID: 6124757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.